Melanoma with BRAF Mutation — Trials

Melanoma with BRAF Mutation — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02729298	First-in-human Study of Oral TP-0903 (a Novel Inhibitor of AXL Kinase) in Patients With Advanced Solid Tumors	completed	Phase 1	177	Sumitomo Pharma America, Inc.INDUSTRY	1	Nov 14, 2023	clinicaltrials
NCT01562899	A Study of MEK162 and AMG 479 in Patients With Selected Solid Tumors	terminated	Phase 1 / Phase 2	77	PfizerINDUSTRY	8	Dec 10, 2020	clinicaltrials